Clinical Trial Update: Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on SLIT with dust mite allergen for allergic rhinitis, spanning Phase 2 and Phase 3, with unknown status and mechanism insights.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• SLIT with dust mite allergen (sublingual immunotherapy with dust mite allergen)

Snippet

Sponsor: People's Hospital of Anshun City of Guizhou Province | Conditions: Allergic Rhinitis | Phase 2, Phase 3 | Status: UNKNOWN